Studies on the mechanism of action of 1-beta-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes.
D000818:Animals; D001665:Binding Sites; D003561:Cytarabine / Q000627:therapeutic use*; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D004273:DNA, Neoplasm / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D066298:In Vitro Techniques; D007942:Leukemia, Experimental / Q000188:drug therapy*; D007962:Leukocytes / Q000187:drug effects*; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D004273:DNA, Neoplasm; D003561:Cytarabine; D014316:Tritium; D004254:DNA Nucleotidyltransferases; D014529:Uridine; D006918:Hydroxyurea